Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
20.39%
↑ 164% above average
Average (27q)
-31.63%
Historical baseline
Range
High:136.67%
Low:-595.45%
Volatility
-2314.9%
Relatively stable
| Period | Value |
|---|---|
| Q4 2025 | 20.39% |
| Q3 2025 | -98.08% |
| Q2 2025 | 22.39% |
| Q1 2025 | 10.67% |
| Q4 2024 | -11.94% |
| Q3 2024 | 5.63% |
| Q2 2024 | 6.58% |
| Q1 2024 | 1.30% |
| Q4 2023 | -13.24% |
| Q3 2023 | -70.00% |
| Q2 2023 | 38.46% |
| Q1 2023 | 15.58% |
| Q4 2022 | 12.50% |
| Q3 2022 | 12.00% |
| Q2 2022 | -5.26% |
| Q1 2022 | -11.76% |
| Q4 2021 | -30.77% |
| Q3 2021 | -8.33% |
| Q2 2021 | 4.76% |
| Q1 2021 | -23.53% |
| Q4 2020 | 53.21% |
| Q3 2020 | -595.45% |
| Q2 2020 | 136.67% |
| Q1 2020 | 7.69% |
| Q4 2019 | -441.67% |
| Q3 2019 | 87.23% |
| Q2 2019 | -10.59% |
| Q1 2019 | 0.00% |